Media center
Each episode of the pharmaceutical expert podcast will feature real conversations on current topics impacting the world of pharmaceutical manufacturing. Join our hosts, Frank O’Loughlin and Elizabeth Doyle, as they uncover exciting real-world insights and practical recommendations straight from experts in the industry. So sit back, relax or go for a walk and listen with some PEP in your step! Here comes PEP talks.
Make sure to subscribe to our channel to stay up to date on current episodes. You will also find them linked in our monthly newsletter, The Batch Report.
Frank O’Loughlin
Strategic Account Manager Software
Körber Business Area Pharma
Elizabeth Doyle
HR Business Partner Software
Körber Business Area Pharma
With Owen Bonner, Director Software Ireland, Körber Business Area Pharma
In pharmaceutical and biotech production, it is crucial to link the right data and understand it in the right way. In this episode, we explore what digitization means, what steps companies need to take to digitize their production, and whether suppliers are keeping pace with the digital revolution.
With Mike Lohmeyer, Vice President of Distribution, Grantek
In the second part of the series, we continue our conversation about Pharma 4.0 and answer the question of what comes first – the factory hardware or the software? We also find out best practices of how to select the ideal software and hardware based on the manufacturer’s goals and requirements.
With Sam Russem, Senior Director, Smart Manufacturing Solutions, Grantek
At this point, Pharma 4.0 could easily be a category of a popular game show. But, would the players get all the questions right? Is there only one correct answer? In the start of a two-part series we will explore the world of Pharma 4.0. We will define the buzzwords and discuss how to set goals for smart manufacturing – whether it is for a Greenfield plant or an established pharma factory.
With Daniel R. Matlis, President & Founder, Axendia, Inc.
What is real and what is a myth when it comes to FDA regulations for pharmaceutical manufacturing? In our first episode of PEP talks, we’ll clear up some myths and misinterpretations of regulatory requirements with our expert guest Daniel R. Matlis, President and Founder of Axendia, Inc., an analyst firm providing trusted advice to life science executives on business, technology and regulatory issues. You won’t want to miss this discussion as commonly held beliefs get busted.
